- The FDA approves Lannett Company's (NYSE:LCI) Abbreviated New Drug Application (ANDA) for its generic version of Lyne Laboratories' Cyproheptadine Hydrochloride Syrup for the symptomatic treatment of allergic reactions.
- The original branded product, Periactin Syrup, was marketed by Merck.
- The U.S. wholesale market is ~$6M.